<html xmlns="http://www.w3.org/1999/xhtml">
<head> 
    <link rel="stylesheet" type="text/css" href="style.css"/> 
</head>

<body>
<table>
<tr><th>match no.</th><th>target id</th><th>target length</th><th>alignment length</th><th>probability</th><th>E-value</th><th>coverage</th><th>match description</th></tr>
<tr><td>1</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/5C9F">5C9F_A</a></td><td>139</td><td>99</td><td>98.6</td><td>6.6E-07</td><td>[&nbsp;-----------------------------------------------&nbsp;]</td><td>ApRick protease; pepsin, ApRick, HYDROLASE; HET: CL; 2.0A {Rickettsia conorii}</td></tr>
<tr><td>2</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/5C9F">5C9F_B</a></td><td>139</td><td>99</td><td>98.6</td><td>6.6E-07</td><td>[&nbsp;-----------------------------------------------&nbsp;]</td><td>ApRick protease; pepsin, ApRick, HYDROLASE; HET: CL; 2.0A {Rickettsia conorii}</td></tr>
<tr><td>3</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/2HS1">2HS1_A</a></td><td>99</td><td>87</td><td>98.5</td><td>1.3E-06</td><td>[&nbsp;---------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>HIV-1 Protease V32I mutant (EC; ultra-high resolution active site surface; HET: 017; 0.84A {Human immunodeficiency virus 1}</td></tr>
<tr><td>4</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3GGA">3GGA_B</a></td><td>99</td><td>88</td><td>98.5</td><td>2.9E-06</td><td>[----------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>V-1 protease; pseudo-symmetrical HIV Protease Inhibitors, Hydrolase; HET: GGW; 2.5A {Human immunodeficiency virus 1}</td></tr>
<tr><td>5</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3OGP">3OGP_B</a></td><td>116</td><td>94</td><td>98.5</td><td>1.2E-06</td><td>[&nbsp;---------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>FIV Protease (E.C.3.4.23.-); aspartyl protease, HIV-like FIV chimera; HET: 017; 1.7A {Feline immunodeficiency virus}</td></tr>
<tr><td>6</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3SLZ">3SLZ_B</a></td><td>132</td><td>93</td><td>98.5</td><td>9.5E-07</td><td>[&nbsp;-----------------------------------------------&nbsp;]</td><td>gag-pro-pol polyprotein; Beta sheet and dimer, Protease; HET: FMT, 3TL; 1.4A {DG-75 Murine leukemia virus}</td></tr>
<tr><td>7</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3S8I">3S8I_A</a></td><td>148</td><td>100</td><td>98.4</td><td>5.3E-06</td><td>[------------------------------------------------&nbsp;]</td><td>Protein DDI1 homolog 1; PROTEASE, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS; HET: PO4; 1.7A {Homo sapiens}</td></tr>
<tr><td>8</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3S8I">3S8I_B</a></td><td>148</td><td>100</td><td>98.4</td><td>6.9E-06</td><td>[------------------------------------------------&nbsp;]</td><td>Protein DDI1 homolog 1; PROTEASE, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS; HET: PO4; 1.7A {Homo sapiens}</td></tr>
<tr><td>9</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/5UPJ">5UPJ_B</a></td><td>99</td><td>89</td><td>98.4</td><td>3.7E-06</td><td>[&nbsp;---------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>HIV-2 PROTEASE, 5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTAM1425_0888</td><td>105</td><td>10</td><td>3NR6_A</td><td>132</td><td>93</td><td>98.4</td><td>9.5E-07</td><td>[&nbsp;-----------------------------------------------&nbsp;]</td><td>PROTEASE P14 (E.C.3.4.23.-); DIMER, PROTEASE, HYDROLASE-INHIBITOR complex; 1.97A {Xenotropic MuLV-related virus VP62}</td></tr>
<tr><td>11</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3ECG">3ECG_B</a></td><td>99</td><td>89</td><td>98.4</td><td>5.6E-06</td><td>[&nbsp;---------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>Protease (E.C.3.4.23.47); HIV-2, aspartic protease, inhibitor, protease-inhibitor; HET: ZN, IMD, 065; 1.18A {Human immunodeficiency virus type 2 (ISOLATE ROD)} SCOP: b.50.1.1</td></tr>
<tr><td>12</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/2FMB">2FMB_A</a></td><td>104</td><td>92</td><td>98.3</td><td>1.1E-05</td><td>[&nbsp;---------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>EQUINE INFECTIOUS ANEMIA VIRUS PROTEASE; ASPARTIC PROTEASE, RETROPEPSIN, RETROVIRUS, EIAV; HET: LP1; 1.8A {Equine infectious anemia virus} SCOP: b.50.1.1</td></tr>
<tr><td>13</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/4Z2Z">4Z2Z_B</a></td><td>146</td><td>99</td><td>98.3</td><td>3.1E-05</td><td>[&nbsp;-----------------------------------------------&nbsp;]</td><td>DNA damage-inducible protein 1; protease, Ddi1, HYDROLASE; 1.8A {Saccharomyces cerevisiae}</td></tr>
<tr><td>14</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/1FIV">1FIV_A</a></td><td>113</td><td>95</td><td>98.3</td><td>3E-06</td><td>[----------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>FIV PROTEASE / INHIBITOR COMPLEX; ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX; 2.0A {Feline immunodeficiency virus} SCOP: b.50.1.1</td></tr>
<tr><td>15</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/4Z2Z">4Z2Z_A</a></td><td>146</td><td>99</td><td>98.3</td><td>2.1E-05</td><td>[&nbsp;-----------------------------------------------&nbsp;]</td><td>DNA damage-inducible protein 1; protease, Ddi1, HYDROLASE; 1.8A {Saccharomyces cerevisiae}</td></tr>
<tr><td>16</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3OXV">3OXV_A</a></td><td>99</td><td>87</td><td>98.2</td><td>3.1E-05</td><td>[&nbsp;---------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>HIV-1 Protease (E.C.3.4.23.16); HIV-1 protease, inhibitor resistance, AIDS; HET: GOL, 478, PO4; 1.75A {HIV-1 M:B_ARV2/SF2}</td></tr>
<tr><td>17</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/2NMZ">2NMZ_A</a></td><td>99</td><td>87</td><td>98.0</td><td>0.00011</td><td>[&nbsp;---------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>PROTEASE (E.C.3.4.23.16); HIV-1 PROTEASE, MUTANT, V82A, DIMER; HET: ROC, SO4; 0.97A {Human immunodeficiency virus 1} SCOP: b.50.1.1</td></tr>
<tr><td>18</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3SQF">3SQF_B</a></td><td>114</td><td>98</td><td>98.0</td><td>3.4E-06</td><td>[&nbsp;------------------------------------------------]</td><td>Protease (E.C.3.4.23.-); folded monomer, retroviral protease folded; 1.6324A {Mason-Pfizer monkey virus}</td></tr>
<tr><td>19</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3LIY">3LIY_E</a></td><td>116</td><td>92</td><td>97.8</td><td>3.1E-05</td><td>[&nbsp;---------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>Protease; Statine, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR complex; HET: PEG; 1.86A {Human T-lymphotropic virus 1}</td></tr>
<tr><td>20</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/2RSP">2RSP_B</a></td><td>124</td><td>91</td><td>97.5</td><td>0.00017</td><td>[&nbsp;&nbsp;--------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>ROUS SARCOMA VIRUS PROTEASE (RSV; HYDROLASE(ASPARTYL PROTEINASE); 2.0A {Rous sarcoma virus} SCOP: b.50.1.1</td></tr>
<tr><td>21</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/1NSO">1NSO_A</a></td><td>107</td><td>91</td><td>97.3</td><td>3.4E-05</td><td>[&nbsp;--------------------------------------------&nbsp;&nbsp;&nbsp;&nbsp;]</td><td> TRYPTOPHAN, VALINE, GLUTAMINE, PROLINE; M-PMV, PROTEASE, VIRUS MATURATION, FOLDED; NMR {Simian retrovirus 1} SCOP: b.50.1.1</td></tr>
<tr><td>22</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/1BAI">1BAI_B</a></td><td>124</td><td>92</td><td>97.3</td><td>0.00038</td><td>[&nbsp;---------------------------------------------&nbsp;&nbsp;&nbsp;]</td><td>ROUS SARCOMA VIRUS PROTEASE, INHIBITOR; PROTEIN-MEDIATED INTERACTION, VIRAL MATURATION, HYDROLASE-HYDROLASE; HET: 0Q4; 2.4A {Rous sarcoma virus} SCOP: b.50.1.1</td></tr>
<tr><td>23</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/2JYS">2JYS_A</a></td><td>107</td><td>80</td><td>95.4</td><td>0.066</td><td>[&nbsp;----------------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>Protease/Reverse transcriptase (E.C.3.4.23.-); retroviral protease, Hydrolase; NMR {Simian foamy virus type 1}</td></tr>
<tr><td>24</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/2PMA">2PMA_A</a></td><td>146</td><td>47</td><td>90.9</td><td>1.1</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;---------------------]</td><td>Uncharacterized protein; APC86035.2, protein Lpg0085, DUF785, Legionella; HET: FMT, ACT; 1.89A {Legionella pneumophila subsp. pneumophila str. Philadelphia 1} SCOP: b.50.1.3</td></tr>
<tr><td>25</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/1FLH">1FLH_A</a></td><td>326</td><td>83</td><td>77.2</td><td>5.2</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-------------------------------------------&nbsp;]</td><td>HUMAN UROPEPSIN (E.C.3.4.23.1); ACID PROTEINASE, HYDROLASE; 2.45A {Homo sapiens} SCOP: b.50.1.2</td></tr>
<tr><td>26</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/5P1T">5P1T_A</a></td><td>330</td><td>90</td><td>74.0</td><td>19</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-------------------------------------------&nbsp;]</td><td>?; fragment screening, method development, aspartic; 1.403A {Cryphonectria parasitica}</td></tr>
<tr><td>27</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/1OEW">1OEW_A</a></td><td>329</td><td>91</td><td>61.6</td><td>50</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;--------------------------------------------&nbsp;]</td><td>ENDOTHIAPEPSIN (E.C.3.4.23.22); HYDROLASE, ASPARTIC PROTEINASE MECHANISM, ATOMIC; HET: SO4; 0.9A {CRYPHONECTRIA PARASITICA} SCOP: b.50.1.2</td></tr>
<tr><td>28</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/1YG9">1YG9_A</a></td><td>330</td><td>85</td><td>61.6</td><td>46</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;------------------------------------------&nbsp;]</td><td>Aspartic protease Bla g 2; Bla g 2, Allegren, HYDROLASE; HET: NAG; 1.3A {Blattella germanica}</td></tr>
<tr><td>29</td><td>1APR_.</td><td>324</td><td>81</td><td>43.9</td><td>1.3E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-----------------------------------------&nbsp;&nbsp;]</td><td>PROTEIN; HYDROLASE (ACID PROTEINASE);{N/A}</td></tr>
<tr><td>30</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/4O66">4O66_C</a></td><td>76</td><td>26</td><td>41.6</td><td>19</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>SWI/SNF-related matrix-associated actin-dependent regulator of; DNA Repair DNA Replication, DNA; HET: SO4; 1.9A {Mus musculus}</td></tr>
<tr><td>31</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/2XFB">2XFB_I</a></td><td>334</td><td>68</td><td>39.6</td><td>14</td><td>[&nbsp;&nbsp;&nbsp;--------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>E1 ENVELOPE GLYCOPROTEIN, E2 ENVELOPE; ALPHAVIRUS, RECEPTOR BINDING, VIRUS, MEMBRANE; 9.0A {CHIKUNGUNYA VIRUS}</td></tr>
<tr><td>32</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3N44">3N44_B</a></td><td>360</td><td>69</td><td>35.2</td><td>18</td><td>[&nbsp;&nbsp;&nbsp;---------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>E3 envelope glycoprotein, E2 envelope; VIRAL PROTEIN, IMMATURE HETERODIMER, ALPHAVIRUS; HET: ACT, NAG; 2.35A {Chikungunya virus}</td></tr>
<tr><td>33</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/4RCT">4RCT_A</a></td><td>365</td><td>68</td><td>30.0</td><td>1.9E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-------------------------------------&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>Restriction endonuclease R.NgoVII (E.C.3.1.21.4); restriction endonuclease, B3 domain, PLD; 2.25A {Neisseria gonorrhoeae}</td></tr>
<tr><td>34</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3N40">3N40_P</a></td><td>401</td><td>69</td><td>29.8</td><td>25</td><td>[&nbsp;&nbsp;&nbsp;---------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>P62 envelope glycoprotein, E1 envelope; VIRAL PROTEIN, IMMATURE HETERODIMER, ALPHAVIRUS; HET: NAG, NDG, ACT; 2.17A {Chikungunya virus}</td></tr>
<tr><td>35</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3J0C">3J0C_H</a></td><td>423</td><td>36</td><td>27.5</td><td>28</td><td>[&nbsp;&nbsp;&nbsp;-----------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>E1 envelope glycoprotein, E2 envelope; alphavirus, bioweapon, VIRUS; 4.8A {Venezuelan equine encephalitis virus}</td></tr>
<tr><td>36</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/1R5V">1R5V_C</a></td><td>180</td><td>16</td><td>26.9</td><td>26</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>H-2 class II histocompatibility antigen; TCR, MHC class II, structural; 2.5A {Mus musculus} SCOP: b.1.1.2, d.19.1.1</td></tr>
<tr><td>37</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/4RD5">4RD5_A</a></td><td>178</td><td>63</td><td>26.9</td><td>2.6E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;----------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>Restriction endonuclease R.NgoVII (E.C.3.1.21.4); restriction endonuclease, B3 DNA binding; 2.7A {Neisseria gonorrhoeae}</td></tr>
<tr><td>38</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/4RDM">4RDM_A</a></td><td>178</td><td>63</td><td>26.1</td><td>2.6E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;----------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>Restriction endonuclease R.NgoVII (E.C.3.1.21.4); restriction endonuclease, B3 domain, protein-DNA; 2.7A {Neisseria gonorrhoeae}</td></tr>
<tr><td>39</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/4D7U">4D7U_B</a></td><td>227</td><td>62</td><td>24.5</td><td>1.8E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>ENDOGLUCANASE II; OXIDOREDUCTASE, LYTIC MONOOXYGENASE, HEMICELLULOSE ACTIVE; HET: GOL; 1.56A {NEUROSPORA CRASSA}</td></tr>
<tr><td>40</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3APR">3APR_E</a></td><td>325</td><td>81</td><td>23.9</td><td>2E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;------------------------------------------&nbsp;]</td><td>ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6) COMPLEX; HYDROLASE, ASPARTIC PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR; 1.8A {Rhizopus microsporus var. chinensis} SCOP: b.50.1.2</td></tr>
<tr><td>41</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3C9X">3C9X_A</a></td><td>329</td><td>85</td><td>23.5</td><td>2E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-------------------------------------------&nbsp;]</td><td>Trichoderma reesei Aspartic protease (E.C.3.4.23.18); aspartic proteinase, Aspartyl protease, Hydrolase; HET: GOL; 1.7A {Trichoderma reesei}</td></tr>
<tr><td>42</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/1UH8">1UH8_A</a></td><td>325</td><td>32</td><td>23.4</td><td>3.3E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;---------------&nbsp;]</td><td>hizopuspepsin I (E.C.3.4.23.6); pepsin, aspartic proteinase, HYDROLASE; 2.3A {Rhizopus microsporus var. chinensis} SCOP: b.50.1.2</td></tr>
<tr><td>43</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/1MPP">1MPP_A</a></td><td>361</td><td>32</td><td>21.9</td><td>1.4E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;---------------&nbsp;]</td><td>PEPSIN (RENIN) (E.C.3.4.23.23); HYDROLASE(ACID PROTEINASE); 2.0A {Rhizomucor pusillus} SCOP: b.50.1.2</td></tr>
<tr><td>44</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/5ACH">5ACH_A</a></td><td>235</td><td>62</td><td>21.3</td><td>2.7E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>LYTIC POLYSACCHARIDE MONOOXYGENASE; OXIDOREDUCTASE, MONOOXYGENASE; HET: NAG, HIC, CL; 1.28A {LENTINUS SIMILIS}</td></tr>
<tr><td>45</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/5ACJ">5ACJ_A</a></td><td>235</td><td>62</td><td>21.3</td><td>2.7E+02</td><td>[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--------------------------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>LYTIC POLYSACCHARIDE MONOOXYGENASE; OXIDOREDUCTASE, MONOOXYGENASE; HET: BGC, HIC, NAG; 1.7A {LENTINUS SIMILIS}</td></tr>
<tr><td>46</td><td><a href="http://www.ebi.ac.uk/pdbe/entry/pdb/3J0F">3J0F_J</a></td><td>423</td><td>36</td><td>20.5</td><td>66</td><td>[&nbsp;&nbsp;&nbsp;-----------------&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</td><td>Capsid protein (E.C.3.4.21.90), E1 envelope; alphavirus, virus assembly, glycoprotein, VIRUS; 7.0A {Sindbis virus}</td></tr>
</table>
</body>
